High-Throughput Measurement and Machine Learning-Based Prediction of Collision Cross Sections for Drugs and Drug Metabolites
Ontology highlight
ABSTRACT:
INSTRUMENT(S): SYNAPT G2-Si
ORGANISM(S): Homo Sapiens (ncbitaxon:9606)
SUBMITTER: 
Libin Xu
PROVIDER: MSV000088549 | MassIVE | Thu Dec 09 11:58:00 GMT 2021
REPOSITORIES: MassIVE
Similar Datasets
Project description:High-throughput IM-MS analysis of drug metabolism incubations prepared from the MicroSource Spectrum Discovery Collection using pooled human liver microsomes and S9 fraction
2021-12-09 | MSV000088549 | GNPS
Project description:Drug metabolite identification is a bottleneck of drug metabolism studies due to the need for time-consuming chromatographic separation and structural confirmation. Ion mobility-mass spectrometry (IM-MS), on the other hand, separates analytes on a rapid (millisecond) time scale and enables the measurement of collision cross section (CCS), a unique physical property related to an ion's gas-phase size and shape, which can be used as an additional parameter for identification of unknowns. A current limitation to the application of IM-MS to the identification of drug metabolites is the lack of reference CCS values. In this work, we assembled a large-scale database of drug and drug metabolite CCS values using high-throughput in vitro drug metabolite generation and a rapid IM-MS analysis with automated data processing. Subsequently, we used this database to train a machine learning-based CCS prediction model, employing a combination of conventional 2D molecular descriptors and novel 3D descriptors, achieving high prediction accuracies (0.8-2.2% median relative error on test set data). The inclusion of 3D information in the prediction model enables the prediction of different CCS values for different protomers, conformers, and positional isomers, which is not possible using conventional 2D descriptors. The prediction models, dmCCS, are available at https://CCSbase.net/dmccs_predictions.
| S-EPMC9165597 | biostudies-literature
Project description:High-resolution mass spectrometry is a promising technique in non-target screening (NTS) to monitor contaminants of emerging concern in complex samples. Current chemical identification strategies in NTS experiments typically depend on spectral libraries, chemical databases, and in silico fragmentation tools. However, small molecule identification remains challenging due to the lack of orthogonal sources of information (e.g., unique fragments). Collision cross section (CCS) values measured by ion mobility spectrometry (IMS) offer an additional identification dimension to increase the confidence level. Thanks to the advances in analytical instrumentation, an increasing application of IMS hybrid with high-resolution mass spectrometry (HRMS) in NTS has been reported in the recent decades. Several CCS prediction tools have been developed. However, limited CCS prediction methods were based on a large scale of chemical classes and cross-platform CCS measurements. We successfully developed two prediction models using a random forest machine learning algorithm. One of the approaches was based on chemicals' super classes; the other model was direct CCS prediction using molecular fingerprint. Over 13,324 CCS values from six different laboratories and PubChem using a variety of ion-mobility separation techniques were used for training and testing the models. The test accuracy for all the prediction models was over 0.85, and the median of relative residual was around 2.2%. The models can be applied to different IMS platforms to eliminate false positives in small molecule identification.
| S-EPMC9572128 | biostudies-literature
Project description:Intelligent Transportation Systems (ITSs) are systems that aim to provide innovative services for road users in order to improve traffic efficiency, mobility and safety. This aspect of safety is of utmost importance for Vulnerable Road Users (VRUs), as these users are typically more exposed to dangerous situations, and their vehicles also possess poorer safety mechanisms when in comparison to regular vehicles on the road. Implementing automatic safety solutions for VRU vehicles is challenging since they have high agility and it can be difficult to anticipate their behavior. However, if equipped with communication capabilities, the generated Vehicle-to-Anything (V2X) data can be leveraged by Machine Learning (ML) mechanisms in order to implement such automatic systems. This work proposes a VRU (motorcyclist) collision prediction system, utilizing stacked unidirectional Long Short-Term Memorys (LSTMs) on top of communication data that is generated using the VEINS simulation framework (coupling the Simulation of Urban MObility (SUMO) and Network Simulator 3 (ns-3) tools). The proposed system performed well in two different scenarios: in Scenario A, it predicted 96% of the collisions, averaging 4.53 s for Average Prediction Time (s) (APT) and with a Correct Decision Percentage (CDP) of 41% and 78 False Positives (FPs); in Scenario B, it predicted 95% of the collisions, with a 4.44 s APT, while the CDP was 43% with 68 FPs. The results show the effectiveness of the approach: using ML methods on V2X data allowed the prediction of most of the simulated accidents. Nonetheless, the presence of a relatively high number of FPs does not allow for the usage of automatic safety features (e.g., emergency breaking in the passenger vehicles); thus, collision avoidance must be achieved manually by the drivers.
| S-EPMC9920954 | biostudies-literature
Project description:Gene expression profiles were generated from 199 primary breast cancer patients. Samples 1-176 were used in another study, GEO Series GSE22820, and form the training data set in this study. Sample numbers 200-222 form a validation set. This data is used to model a machine learning classifier for Estrogen Receptor Status. RNA was isolated from 199 primary breast cancer patients. A machine learning classifier was built to predict ER status using only three gene features.
2013-01-01 | E-GEOD-29210 | biostudies-arrayexpress
Project description:We present a machine learning (ML) method to accelerate the nuclear ensemble approach (NEA) for computing absorption cross sections. ML-NEA is used to calculate cross sections on vast ensembles of nuclear geometries to reduce the error due to insufficient statistical sampling. The electronic properties-excitation energies and oscillator strengths-are calculated with a reference electronic structure method only for a relatively few points in the ensemble. The KREG model (kernel-ridge-regression-based ML combined with the RE descriptor) as implemented in MLatom is used to predict these properties for the remaining tens of thousands of points in the ensemble without incurring much of additional computational cost. We demonstrate for two examples, benzene and a 9-dicyanomethylene derivative of acridine, that ML-NEA can produce statistically converged cross sections even for very challenging cases and even with as few as several hundreds of training points.
| S-EPMC7511037 | biostudies-literature
Project description:The collision cross section (CCS) values derived from ion mobility spectrometry can be used to improve the accuracy of compound identification. Here, we have developed the Structure included graph merging with adduct method for CCS prediction (SigmaCCS) based on graph neural networks using 3D conformers as inputs. A model was trained, evaluated, and tested with >5,000 experimental CCS values. It achieved a coefficient of determination of 0.9945 and a median relative error of 1.1751% on the test set. The model-agnostic interpretation method and the visualization of the learned representations were used to investigate the chemical rationality of SigmaCCS. An in-silico database with 282 million CCS values was generated for three different adduct types of 94 million compounds. Its source code is publicly available at https://github.com/zmzhang/SigmaCCS . Altogether, SigmaCCS is an accurate, rational, and off-the-shelf method to directly predict CCS values from molecular structures.
| S-EPMC10319785 | biostudies-literature
Project description:Successful drug administration to the central nervous system requires accurate adjustment of the drugs' molecular properties. Therefore, structure-derived descriptors of potential brain therapeutic agents are essential for an early evaluation of pharmacokinetics during drug development. The collision cross section (CCS) of molecules was recently introduced as a novel measurable parameter to describe blood-brain barrier (BBB) permeation. This descriptor combines molecular information about mass, structure, volume, branching and flexibility. As these chemical properties are known to influence cerebral pharmacokinetics, CCS determination of new drug candidates may provide important additional spatial information to support existing models of BBB penetration of drugs. Besides measuring CCS, calculation is also possible; but however, the reliability of computed CCS values for an evaluation of BBB permeation has not yet been fully investigated. In this work, prediction tools based on machine learning were used to compute CCS values of a large number of compounds listed in drug libraries as negative or positive with respect to brain penetration (BBB+ and BBB- compounds). Statistical evaluation of computed CCS and several other descriptors could prove the high value of CCS. Further, CCS-deduced maximum molecular size of BBB+ drugs matched the dimensions of BBB pores. A threshold for transcellular penetration and possible permeation through pore-like openings of cellular tight-junctions is suggested. In sum, CCS evaluation with modern in silico tools shows high potential for its use in the drug development process.
| S-EPMC8703848 | biostudies-literature
Project description:Early and accurate detection of side effects is critical for the clinical success of drugs under development. Here, we aim to predict unknown side effects for drugs with a small number of side effects identified in randomized controlled clinical trials. Our machine learning framework, the geometric self-expressive model (GSEM), learns globally optimal self-representations for drugs and side effects from pharmacological graph networks. We show the usefulness of the GSEM on 505 therapeutically diverse drugs and 904 side effects from multiple human physiological systems. Here, we also show a data integration strategy that could be adopted to improve the ability of side effect prediction models to identify unknown side effects that might only appear after the drug enters the market.
| S-EPMC9795366 | biostudies-literature
Project description:Gene expression profiles were generated from 199 primary breast cancer patients. Samples 1-176 were used in another study, GEO Series GSE22820, and form the training data set in this study. Sample numbers 200-222 form a validation set. This data is used to model a machine learning classifier for Estrogen Receptor Status.
2013-01-01 | GSE29210 | GEO